Ładuje się......
Oxaliplatin-Based Platinum(IV) Prodrug Bearing Toll-like Receptor 7 Agonist for Enhanced Immunochemotherapy
[Image: see text] A combination of platinum drugs with immunotherapy has shown promising anticancer effects, especially in the drug resistance cancer model. Herein, a new type of immunochemotherapeutic was designed by tethering the toll-like receptor 7 (TLR7) agonist on the axial position of oxalipl...
Zapisane w:
| Wydane w: | ACS Omega |
|---|---|
| Główni autorzy: | , , , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
American Chemical
Society
2019
|
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6964279/ https://ncbi.nlm.nih.gov/pubmed/31956823 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsomega.9b03381 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|